Venus Remedies Limited — Board Meeting, 04-02-2025: Outcome of Board Meeting

The board meeting outcome includes the review and approval of the standalone and consolidated financial results for the quarter and nine months ended December 31, 2024. Key highlights show total income at ₹178.39 Cr and profit after tax of ₹19.60 Cr for the quarter, with the company recognizing ₹9.91 Cr as an exceptional item related to time-barred unsecured FCCB liability write-off. The board also noted a capital reserve transfer of ₹28.77 Cr due to this write-off, alongside a comprehensive income of ₹17.85 Cr for the period.